Loading interface...

Ordilan-T Tablet

Manufactured byORDAIN HEALTHCARE PVT LTD
ContainsCilnidipine (10 mg) + Telmisartan (40 mg)
Description
Ordilan-T Tablet is a combination of Cilnidipine and Telmisartan. It is used in the treatment of high blood pressure. This medicine relaxes the blood vessels, thus controlling your blood pressure. Ordilan-T Tablet can cause side effects like stomach pain, swelling in your hands and feet, irregular heartbeats, headache, etc. Consult your doctor if these side effects persist or worsen. This medicine can cause dizziness, therefore avoid activities that require mental focus like driving vehicles or operating machines. Ordilan-T Tablet can be taken with or without food, as prescribed by your doctor. Your doctor will determine the dose based on your condition. Take Ordilan-T Tablet at the same time every day to maintain a constant level of this medicine in your blood. Avoid the discontinuation of this medicine without consulting your doctor, as your condition may become worse. Ordilan-T Tablet is not recommended if you are allergic to it. Inform your doctor if you have any heart, liver, or kidney problems. Inform your doctor if you are taking any other medicines or supplements as they may interact with this medicine and increase the risk of side effects. Consult your doctor if you are pregnant or are breastfeeding.

Side effects

Major & minor side effects for Ordilan-T Tablet

  • Dizziness
  • Increased heartbeat
  • Difficult or painful urination
  • Stomach pain
  • Diarrhoea
  • Back pain
  • Weakness
  • Cough
  • Low blood pressure
  • Skin rash
  • Decreased sexual urge
  • Increased urination frequency
  • Chest pain
  • Headache

Uses of Ordilan-T Tablet

What is it prescribed for?

  • Hypertension
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of Ordilan-T Tablet can be observed within 2 hours.
  • How long do the effects of this medicine last?
    Ordilan-T Tablet may remain active in your body for 24 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment of Ordilan-T Tablet as it may cause further decrease in your blood pressure. You may experience symptoms such as dizziness, fainting, change in heart rate, etc. Avoid performing activities such as driving or operating machines.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported for Ordilan-T Tablet.
  • Can this medicine be taken during pregnancy?
    Ordilan-T Tablet is not recommended for use in pregnancy as it can harm your foetus. Consult your doctor if you are pregnant.
  • Can this medicine be taken while breast-feeding?
    Ordilan-T Tablet is not recommended for use while breastfeeding as it is not known if this medicine passes into breastmilk. Consult your doctor if you are breastfeeding.

Allergy

Ordilan-T Tablet is not recommended for use if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, swelling and/or itching (especially in the face, lips, throat, etc.), dizziness, breathing difficulty, etc.

Aliskiren

Taking Ordilan-T Tablet and Aliskiren (a medicine used to reduce high blood pressure) together is not recommended as it may lead to kidney damage, low blood pressure, and hyperkalaemia (high potassium levels in the blood). This risk is especially higher if you have diabetes or kidney problems.

Severe liver impairment

Ordilan-T Tablet is not recommended if you have severe liver problems. This medicine may get accumulated in the liver and further lead to liver damage and increased risk of side effects.
Warnings for special population

Pregnancy

Ordilan-T Tablet is not recommended for use in pregnancy as it can harm your foetus. Consult your doctor if you are pregnant.

Breast-feeding

Ordilan-T Tablet is not recommended for use while breastfeeding as it is not known if this medicine passes into breastmilk. Consult your doctor if you are breastfeeding.
General warnings

Aortic stenosis

Ordilan-T Tablet should be used with caution if you have aortic stenosis (narrowing or blockage of the aortic valve that regulates blood flow in the chambers of the heart). This medicine slows down the blood flow which may increase the risk of very low blood pressure. It is recommended that you monitor your blood pressure regularly while you take this medicine.

Use in Children

Ordilan-T Tablet is not recommended for use in children below 18 years since the safety and efficacy of use are not clinically established.

Renal artery stenosis

Use Ordilan-T Tablet with caution if you have renal artery stenosis (narrowing or blockage of blood vessels that carry blood to the kidneys) as it may cause uncontrolled high blood pressure, altered kidney function, water retention, and swelling in the body (majorly in limbs). Your kidney function and clinical condition will be closely monitored by your doctor while you are taking this medicine.

Drug withdrawal

Avoid abrupt discontinuation of Ordilan-T Tablet as it may worsen the condition such as angina (chest pain). Your doctor may gradually reduce the dose based on your condition to avoid undesirable effects.

Hyperkalaemia

Use of Ordilan-T Tablet may lead to hyperkalaemia (increase the potassium levels in your blood). This may cause side effects such as cardiac rhythm irregularities. Avoid potassium-rich foods (potatoes, bananas) and other medicines that may increase potassium levels (ACE inhibitors and potassium supplements) during treatment with this medicine.

Driving or operating Machines

Use of Ordilan-T Tablet may cause symptoms such as drowsiness and/or dizziness. Avoid performing activities that requires high mental alertness like driving vehicles or operating heavy machines during treatment with this medicine.

Missed Dose

Take the missed dose of Ordilan-T Tablet as soon as you remember. If it is time for your next scheduled dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Never take more than the prescribed dose. Contact your doctor immediately if you suspect an overdose of Ordilan-T Tablet for further guidance.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment of Ordilan-T Tablet as it may cause further decrease in your blood pressure. You may experience symptoms such as dizziness, fainting, change in heart rate, etc. Avoid performing activities such as driving or operating machines.
Interaction with Medicine

Carbamazepine

Dexamethasone

Diclofenac

Captopril

Insulin

Primaquine

Cimetidine

Disease interactions

Congestive heart failure

Heart failure occurs when your heart muscle is not able to pump blood normally. Ordilan-T Tablet should be used with caution if you have conditions such as heart failure because this medicine may worsen your condition. Your doctor will closely monitor the functioning of your heart while you take this medicine.

Hypotension

Ordilan-T Tablet should be used with caution if you have hypotension (low blood pressure) as this medicine may further lower your blood pressure and worsen your condition. Monitor your blood pressure regularly while you are taking this medicine.

Kidney Disease

Ordilan-T Tablet should be used with caution if you have kidney disease as a diseased kidney will not filter the medicine properly. Your doctor can suggest another suitable medicine or adjust the dose according to your kidney function.

Liver Disease

Ordilan-T Tablet should be used with caution if you have liver problems as it is broken down in the liver. Liver damage may lead to the accumulation of this medicine and increases the risk of side effects. Your doctor may suggest tests to monitor your liver functions and suggest appropriate dose adjustments based on your condition.
Food interactions
Consumption of grapefruit juice is not recommended as it increases the concentration of Ordilan-T Tablet in your body and increase the risk of side effects.
Lab interactions

Urinary vanillylmandelic acid

Urinary vanillylmandelic acid test is performed to determine the presence of certain tumours. Inform your doctor or the lab technician about the use of Ordilan-T Tablet as this medicine is likely to give a false positive result.
Take Ordilan-T Tablet exactly as advised by your doctor. Do not break, crush, or chew the tablet. Take this medicine at the same time everyday for the ease of remembering. Avoid the discontinuation of Ordilan-T Tablet without consulting your doctor. Exercise regularly and eat a healthy diet as it helps in maintaining your blood pressure. Avoid consuming alcohol or grapefruit juice while taking Ordilan-T Tablet as it can increase the risk of side effects. Ordilan-T Tablet can make you feel dizzy. Be careful while standing up from sitting or lying down position. Avoid performing activities such as driving or operating machines if you feel dizzy or drowsy. Your doctor will suggest you to monitor your blood pressure frequently. Consult your doctor if you experience any unusual symptoms.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
Ordilan-T Tablet is composed of Telmisartan and Clinidipine. Telmisartan and Cilnidipine both relax the blood vessels, thus improving blood flow and controlling high blood pressure.
Legal Status

Unknown

Unknown

Unknown

Unknown

Classification

Category

Angiotensin II inhibitors with calcium channel blockers, Antihypertensive combinations

Schedule

Schedule H

Centaurpharma.com. 2021. [online] Available at: < [Accessed 31 August 2021].

https://www.centaurpharma.com/downloads/TELMITRUST%20LN.pdf>

Pubchem.ncbi.nlm.nih.gov. 2021. Cilnidipine. [online] Available at: < [Accessed 31 August 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/cilnidipine#section=Top>

Dailymed.nlm.nih.gov. 2021. These highlights do not include all the information needed to use TELMISARTAN TABLETS safely and effectively. See full prescribing information for TELMISARTAN TABLETS . TELMISARTAN tablets, for oral use Initial U.S. Approval: 1998. [online] Available at: < [Accessed 31 August 2021].

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1a907a7-fad9-a860-8639-4c6136c85734>

Medicaldialogues.in. 2021. [online] Available at: < [Accessed 31 August 2021].

https://medicaldialogues.in/uploads/2020/05/20/file_upload-129071.pdf>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 27 Jun 2022

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.